IBDEI1T9 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,30315,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30315,1,3,0)
 ;;=3^Osteomyelitis,Acute Hematogenous,Unspec Site
 ;;^UTILITY(U,$J,358.3,30315,1,4,0)
 ;;=4^M86.00
 ;;^UTILITY(U,$J,358.3,30315,2)
 ;;=^5014497
 ;;^UTILITY(U,$J,358.3,30316,0)
 ;;=M86.50^^135^1374^59
 ;;^UTILITY(U,$J,358.3,30316,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30316,1,3,0)
 ;;=3^Osteomyelitis,Chronic Hematogenous,Unspec Site
 ;;^UTILITY(U,$J,358.3,30316,1,4,0)
 ;;=4^M86.50
 ;;^UTILITY(U,$J,358.3,30316,2)
 ;;=^5014607
 ;;^UTILITY(U,$J,358.3,30317,0)
 ;;=M86.30^^135^1374^60
 ;;^UTILITY(U,$J,358.3,30317,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30317,1,3,0)
 ;;=3^Osteomyelitis,Chronic Multifocal,Unspec Site
 ;;^UTILITY(U,$J,358.3,30317,1,4,0)
 ;;=4^M86.30
 ;;^UTILITY(U,$J,358.3,30317,2)
 ;;=^5014559
 ;;^UTILITY(U,$J,358.3,30318,0)
 ;;=M86.8X9^^135^1374^63
 ;;^UTILITY(U,$J,358.3,30318,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30318,1,3,0)
 ;;=3^Osteomyelitis,Unspec Sites
 ;;^UTILITY(U,$J,358.3,30318,1,4,0)
 ;;=4^M86.8X9
 ;;^UTILITY(U,$J,358.3,30318,2)
 ;;=^5014655
 ;;^UTILITY(U,$J,358.3,30319,0)
 ;;=M86.60^^135^1374^61
 ;;^UTILITY(U,$J,358.3,30319,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30319,1,3,0)
 ;;=3^Osteomyelitis,Chronic,Unspec Site
 ;;^UTILITY(U,$J,358.3,30319,1,4,0)
 ;;=4^M86.60
 ;;^UTILITY(U,$J,358.3,30319,2)
 ;;=^5014630
 ;;^UTILITY(U,$J,358.3,30320,0)
 ;;=M86.40^^135^1374^56
 ;;^UTILITY(U,$J,358.3,30320,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30320,1,3,0)
 ;;=3^Osteomyelitis w/ Draining Sinus,Chronic,Unspec Site
 ;;^UTILITY(U,$J,358.3,30320,1,4,0)
 ;;=4^M86.40
 ;;^UTILITY(U,$J,358.3,30320,2)
 ;;=^5014583
 ;;^UTILITY(U,$J,358.3,30321,0)
 ;;=R50.2^^135^1374^23
 ;;^UTILITY(U,$J,358.3,30321,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30321,1,3,0)
 ;;=3^Fever,Drug-Induced
 ;;^UTILITY(U,$J,358.3,30321,1,4,0)
 ;;=4^R50.2
 ;;^UTILITY(U,$J,358.3,30321,2)
 ;;=^5019507
 ;;^UTILITY(U,$J,358.3,30322,0)
 ;;=R50.9^^135^1374^27
 ;;^UTILITY(U,$J,358.3,30322,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30322,1,3,0)
 ;;=3^Fever,Unspec
 ;;^UTILITY(U,$J,358.3,30322,1,4,0)
 ;;=4^R50.9
 ;;^UTILITY(U,$J,358.3,30322,2)
 ;;=^5019512
 ;;^UTILITY(U,$J,358.3,30323,0)
 ;;=R76.11^^135^1374^1
 ;;^UTILITY(U,$J,358.3,30323,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30323,1,3,0)
 ;;=3^Abnormal Reaction to TB Test w/o Active TB
 ;;^UTILITY(U,$J,358.3,30323,1,4,0)
 ;;=4^R76.11
 ;;^UTILITY(U,$J,358.3,30323,2)
 ;;=^5019570
 ;;^UTILITY(U,$J,358.3,30324,0)
 ;;=Z21.^^135^1374^30
 ;;^UTILITY(U,$J,358.3,30324,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30324,1,3,0)
 ;;=3^HIV Asymptomatic,Infection Status
 ;;^UTILITY(U,$J,358.3,30324,1,4,0)
 ;;=4^Z21.
 ;;^UTILITY(U,$J,358.3,30324,2)
 ;;=^5062777
 ;;^UTILITY(U,$J,358.3,30325,0)
 ;;=B37.0^^135^1374^16
 ;;^UTILITY(U,$J,358.3,30325,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30325,1,3,0)
 ;;=3^Candidal Stomatitis (Oral Thrush)
 ;;^UTILITY(U,$J,358.3,30325,1,4,0)
 ;;=4^B37.0
 ;;^UTILITY(U,$J,358.3,30325,2)
 ;;=^5000612
 ;;^UTILITY(U,$J,358.3,30326,0)
 ;;=B97.10^^135^1374^22
 ;;^UTILITY(U,$J,358.3,30326,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30326,1,3,0)
 ;;=3^Enterovirus,Unspec,as Cause of Disease
 ;;^UTILITY(U,$J,358.3,30326,1,4,0)
 ;;=4^B97.10
 ;;^UTILITY(U,$J,358.3,30326,2)
 ;;=^5000861
 ;;^UTILITY(U,$J,358.3,30327,0)
 ;;=R50.82^^135^1374^24
 ;;^UTILITY(U,$J,358.3,30327,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30327,1,3,0)
 ;;=3^Fever,Postprocedural
 ;;^UTILITY(U,$J,358.3,30327,1,4,0)
 ;;=4^R50.82
 ;;^UTILITY(U,$J,358.3,30327,2)
 ;;=^5019509
 ;;^UTILITY(U,$J,358.3,30328,0)
 ;;=R50.83^^135^1374^26
